Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Cash Flow Reinvestment Rate
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Cash Flow Reinvestment Rate of 0.68x as of December 2025, reinvesting $27.77 Million (capex $27.77 Million ) from operating cash flow of $41.05 Million. Check Zhengye Biotechnology Holding Limited Or (ZYBT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhengye Biotechnology Holding Limited Ordinary Shares Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. Explore Zhengye Biotechnology Holding Limited Or cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year capital reinvestment analysis for Zhengye Biotechnology Holding Limited Ordinary Shares. For live market cap and broader valuation context, see Zhengye Biotechnology Holding Limited Or market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | $27.77 Million | $41.05 Million | $27.77 Million | ▲ +0.0% |
| 2024 | 0.68x | $27.77 Million | $41.05 Million | $27.77 Million | ▲ +39.5% |
| 2023 | 0.48x | $23.36 Million | $48.18 Million | $11.60 Million | ▼ -84.6% |
| 2022 | 3.15x | $54.66 Million | $17.34 Million | $27.33 Million | ▲ +90.4% |
| 2021 | 1.66x | $52.67 Million | $31.81 Million | $26.40 Million | — |